H. Lundbeck A/S (HLBBF) Discusses PROCEED Trial Results and Data Presented at AHS on Bokunebart for Headache Treatment Transcript
Source: SeekingAlpha
2026-06-05 16:22:56 ET
H. Lundbeck A/S (HLBBF) Discusses PROCEED Trial Results and Data Presented at AHS on Bokunebart for Headache Treatment June 5, 2026 9:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
H. Lundbeck A/S (HLBBF) Discusses PROCEED Trial Results and Data Presented at AHS on Bokunebart for Headache Treatment Transcript
H. Lundbeck
NASDAQ: HLBBF
HLBBF Trading
0.0% G/L:
$6.55 Last:
480 Volume:
$6.55 Open:
